211 related articles for article (PubMed ID: 34246298)
1. DNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies.
Morival JLP; Widyastuti HP; Nguyen CHH; Zaragoza MV; Downing TL
Clin Epigenetics; 2021 Jul; 13(1):139. PubMed ID: 34246298
[TBL] [Abstract][Full Text] [Related]
2. Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.
Cheedipudi SM; Matkovich SJ; Coarfa C; Hu X; Robertson MJ; Sweet M; Taylor M; Mestroni L; Cleveland J; Willerson JT; Gurha P; Marian AJ
Circ Res; 2019 Apr; 124(8):1198-1213. PubMed ID: 30739589
[TBL] [Abstract][Full Text] [Related]
3. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of fibroblasts in a family with LMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesis.
Widyastuti HP; Norden-Krichmar TM; Grosberg A; Zaragoza MV
BMC Med Genet; 2020 Jul; 21(1):152. PubMed ID: 32698886
[TBL] [Abstract][Full Text] [Related]
5. A Novel Truncating LMNA Mutation in Patients with Cardiac Conduction Disorders and Dilated Cardiomyopathy.
Kawakami H; Ogimoto A; Tokunaga N; Nishimura K; Kawakami H; Higashi H; Iio C; Kono T; Aono J; Uetani T; Nagai T; Inoue K; Suzuki J; Ikeda S; Okura T; Ohyagi Y; Tabara Y; Higaki J
Int Heart J; 2018 May; 59(3):531-541. PubMed ID: 29628476
[TBL] [Abstract][Full Text] [Related]
6. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
[TBL] [Abstract][Full Text] [Related]
7. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
[TBL] [Abstract][Full Text] [Related]
8. Lamin A/C mutations in dilated cardiomyopathy.
Tesson F; Saj M; Uvaize MM; Nicolas H; Płoski R; Bilińska Z
Cardiol J; 2014; 21(4):331-42. PubMed ID: 24846508
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes.
Shah PP; Lv W; Rhoades JH; Poleshko A; Abbey D; Caporizzo MA; Linares-Saldana R; Heffler JG; Sayed N; Thomas D; Wang Q; Stanton LJ; Bedi K; Morley MP; Cappola TP; Owens AT; Margulies KB; Frank DB; Wu JC; Rader DJ; Yang W; Prosser BL; Musunuru K; Jain R
Cell Stem Cell; 2021 May; 28(5):938-954.e9. PubMed ID: 33529599
[TBL] [Abstract][Full Text] [Related]
10. An alpha-helix variant p.Arg156Pro in LMNA as a cause of hereditary dilated cardiomyopathy: genetics and bioinfomatics exploration.
Chang L; Huang R; Chen J; Li G; Shi G; Xu B; Wang L
BMC Med Genomics; 2023 Oct; 16(1):229. PubMed ID: 37784143
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy.
Zhang X; Shao X; Zhang R; Zhu R; Feng R
Clin Epigenetics; 2021 Jan; 13(1):3. PubMed ID: 33407844
[TBL] [Abstract][Full Text] [Related]
12. TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy.
Yamada S; Ko T; Ito M; Sassa T; Nomura S; Okuma H; Sato M; Imasaki T; Kikkawa S; Zhang B; Yamada T; Seki Y; Fujita K; Katoh M; Kubota M; Hatsuse S; Katagiri M; Hayashi H; Hamano M; Takeda N; Morita H; Takada S; Toyoda M; Uchiyama M; Ikeuchi M; Toyooka K; Umezawa A; Yamanishi Y; Nitta R; Aburatani H; Komuro I
Sci Adv; 2023 Apr; 9(15):eade7047. PubMed ID: 37058558
[TBL] [Abstract][Full Text] [Related]
13. [Cardiac manifestations of laminopathies].
Brette S; Penisson-Besnier I; Dupuis JM; Bonne G; Victor J
Arch Mal Coeur Vaiss; 2004 Oct; 97(10):973-7. PubMed ID: 16008174
[TBL] [Abstract][Full Text] [Related]
14. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity.
Tan CY; Chan PS; Tan H; Tan SW; Lee CJM; Wang JW; Ye S; Werner H; Loh YJ; Lee YL; Ackers-Johnson M; Foo RSY; Jiang J
J Transl Med; 2023 Oct; 21(1):690. PubMed ID: 37840136
[TBL] [Abstract][Full Text] [Related]
15. Lamin A K97E leads to NF-κB-mediated dysfunction of inflammatory responses in dilated cardiomyopathy.
Sengupta D; Sengupta K
Biol Cell; 2024 Mar; 116(3):e2300094. PubMed ID: 38404031
[TBL] [Abstract][Full Text] [Related]
16. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
[TBL] [Abstract][Full Text] [Related]
17. A novel deletion mutation accompanied by a point mutation in Lamin A/C gene: Screened from a dilated cardiomyopathy family.
Jia H; Sun Y; Yao W; Chen Z; Yang S; Wang C; Lu S
Perfusion; 2023 May; 38(4):826-836. PubMed ID: 35514053
[TBL] [Abstract][Full Text] [Related]
18. An LMNA synonymous variant associated with severe dilated cardiomyopathy: Case report.
Gao S; Mumme-Monheit A; Chen SN; Spector EB; Slavov D; Baralle FE; Bristow MR; Mestroni L; Taylor MRG;
Am J Med Genet A; 2022 Feb; 188(2):600-605. PubMed ID: 34652067
[TBL] [Abstract][Full Text] [Related]
19. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
[TBL] [Abstract][Full Text] [Related]
20. Creatine and L-carnitine attenuate muscular laminopathy in the LMNA mutation transgenic zebrafish.
Pan SW; Wang HD; Hsiao HY; Hsu PJ; Tseng YC; Liang WC; Jong YJ; Yuh CH
Sci Rep; 2024 Jun; 14(1):12826. PubMed ID: 38834813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
